AstraZeneca PLC is 176.1x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($286.27 B vs $1.63 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRDN | AZN |
|---|---|---|
| Market cap | $1.63 B | $286.27 B |
| US-listed rank | #2249 | #45 |
| Revenue (latest FY) | $4.00M | - |
| Net income (latest FY) | -$342.60M | - |
| Net margin | -8558.6% | - |
| SEC filings | 794 | 1,004 |
AstraZeneca PLC is 176.1x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($286.27 B vs $1.63 B).
Full pages: Viridian Therapeutics, Inc.DE and AstraZeneca PLC, or browse the full rankings.